Citation

Helene Hardy, Pharm.D., Lori Esch, Pharm.D., Gene D. Morse, Pharm.D. Glucose disorders associated with HIV and its drug therapy. Annals of Pharmacotherapy. 2001 Mar 01; 35(3):343-51.

Citation

Catherine Leport, M.D., J. Franck, Genevieve Chene, F. Derouin, JL Ecobichon, Sophie Pueyo, Jose Miro, Benjamin J. Luft, M.D., Philippe Morlat, M.D., H. Dumon. Immunoblot profile as predictor of toxoplasmic encephalitis in patients infected with human immunodeficiency virus. Clinical and Diagnostic Laboratory Immunology. 2001 May 01; 8(3):579-84.

Citation

David M. Simpson, M.D., David Katzenstein, M.D., Bettina Haidich, M.Sc., David Millington, Constantin Yiannoutsos, Ph.D., Giovanni Schifitto, M.D., Justin C. McArthur, M.B.B.S., M.P.H. Plasma carnitine in HIV-associated neuropathy. AIDS. 2001 Nov 09; 15(16):2207-8.

Citation

Mark Mirochnick, M.D., Ellen Rae Cooper, M.P.H., M.D., Edmund Capparelli, Pharm.D., Kenneth McIntosh, M.D., Jane C. Lindsey, Sc.D., Ph.D., Jing Xu, M.S., David P. Jacobus, M.D., Lynne M. Mofenson, M.D., F.A.A.P., Vincent R. Bonagura, M.D., Sharon Appelbaum Nachman, M.D., Ram Yogev, M.D., Stephen A. Spector, M.D. Population pharmacokinetics of dapson in children with human immunodeficiency virus infection. Clinical Pharmacology & Therapeutics. 2001 Jul 07; 1(70):24-32.

Citation

Elizabeth Livingston, M.D., Arlene D. Bardeguez, M.D., M.P.H., F.A.C.O.G., Jorge Gandia, M.D., Mary Jo O'Sullivan, M.D., Sharon Huang, M.S., Ross E. McKinney, Jr., M.D., W. N.P. Herbert, Pamela A. Clax, D.P.M., Yi Wang, Ph.D., Sheran Patel, D.O., Ruth E. Dickover, Ph.D., Jashvant D. Unadkat, Ph.D. Maternal and Fetal Clinical Effects Of Didanosine (ddl) Use In Pregnancies Complicated By HIV-1 Infection. American Journal of Obstetrics and Gynecology. 2001 Aug 01;

Citation

Paul Palumbo, M.D., William T. Shearer, M.D., Ph.D. Duration of ruptured mambranes and vertical transmission of HIV-1: a meta-analysis from 15 prospective cohort studies. AIDS. 2001 Aug 30; 15:357-368.

Citation

Jean Marie Arduino, Sc.D., Margaret A. Fischl, M.D., Kenneth Stanley, Ph.D., Ann C. Collier, M.D., Donna Spiegelman, Sc.D. Do HIV type 1 RNA levels provide additional prognostic value to CD4(+) T lymphocyte counts in patients with advanced HIV type 1 infection?. AIDS Research and Human Retroviruses. 2001 Aug 10; 17(12):1099-105.

Citation

Anura L. Jayewardene, Ph.D., Brian Kearney, Pharm.D., J. Stone, John G. Gambertoglio, Pharm.D., Francesca Aweeka, Pharm.D. An LC-MS-MS method for the determination of indinavir, an HIV-1 protease inhibitor, in human plasma. Journal of Pharmaceutical and Biomedical Analysis. 2001 May 01; 25(2):309-17.

Citation

Dianne M. Finkelstein, Ph.D., David A. Schoenfeld, Ph.D. Comparing treatment strategies using a synthesized clinical trial: An analysis of late versus early use of bactrim for AIDS patients. Journal of Statistical Planning and Inference. 2001 Jun 01; 96(1):179-189.